Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call presents mixed signals: While revenue and gross profit increased, the net loss remains significant, and there's a notable goodwill impairment. The Q&A highlights potential product expansions and partnerships, but lacks concrete timelines or details. The company's cautious communication suggests uncertainty. Market reaction is likely neutral, as positive developments are offset by financial challenges and vague strategic plans.
Q4 2023 Revenue $2.4 million, a 13% increase from $2.1 million in the same period last year due to 8% higher unit sales and a 5% increase in average sell price.
Q4 2023 Gross Profit $1.6 million, up 21% from the same period last year, driven by an increase in year-over-year sales and margin improvement.
Q4 2023 Gross Margin 66%, a 450 bps increase over the same quarter last year, due to improvements in inbound and outbound shipping costs.
Q4 2023 Total Operating Expenses $11 million, which included a non-cash goodwill impairment charge of $7.8 million; excluding the impairment, expenses were $3.2 million, a 14% decrease from $3.7 million in the same period last year.
Q4 2023 G&A Expenses $2.5 million, an improvement of 21% from $3.2 million during the same quarter last year, due to cost reductions in salary and wages, professional fees, recruiting expenses, and the elimination of franchise tax payments.
Q4 2023 Net Loss $1.73 per share on 1.7 million weighted shares outstanding, compared to a net loss of $5.23 per share on 0.5 million weighted shares outstanding in the prior quarter.
Full Year 2023 Revenue $9.9 million, a 17% decrease compared to the prior year's $11.9 million, driven by 22% lower unit sales, partially offset by a 5% increase in average sale price.
Full Year 2023 Gross Profit $6.7 million, down from $7.2 million in the prior year, with margin improvement measures helping to offset the impact of lower revenues.
Full Year 2023 Gross Margin 67.1%, a 640 bps increase from the full year 2022, resulting from lower inbound and outbound shipping costs.
Full Year 2023 Total Operating Expenses $14.2 million, relatively unchanged compared to $14.1 million in the year ended 2022, excluding the goodwill impairment charge.
Full Year 2023 G&A Expenses $11.8 million, up just 1% from full year 2022, indicating stability in operational costs.
Full Year 2023 Net Loss $4.03 per share, compared with the prior year's net loss of $15.15 per share, excluding the impact of the impairment charge and deemed dividend.
Full Year 2023 Cash and Cash Equivalents $6.4 million compared with $7 million at the end of 2022.
2023 Gross Proceeds from Issuance $6.4 million from issuing common stock, warrants, and the exercise of common stock purchase warrants.
New Product Launches: Introduced Freedom Alert Plus, a Wi-Fi-enabled device with patented fall detection technology and two-way communication. Released Freedom Alert Mini, featuring GPS monitoring and geofencing capabilities. Launched Aster, a subscription-based software application for personal safety.
Market Expansion: Expanded distribution channels through Amazon and e-commerce store. Exploring partnerships with health B2B organizations and government agencies.
Operational Efficiencies: Achieved a 21% increase in gross profit and improved gross margin to 66% in Q4 2023. Reduced total operating expenses by 14% excluding goodwill impairment.
Strategic Shifts: Focused on advancing the Caring Platform as a Service (CPaaS) model. Emphasized recurring revenue model through new product features and licensing opportunities.
Competitive Pressures: LogicMark faces competitive pressures in the Personal Emergency Response Systems (PERS) market, particularly as they expand their product offerings and distribution channels. The need to differentiate their products in a crowded market is a challenge.
Regulatory Issues: The company operates in a heavily regulated industry, which may pose risks related to compliance with health and safety standards, particularly as they expand into government contracts and partnerships.
Supply Chain Challenges: There are potential supply chain challenges that could impact the availability and cost of components necessary for their technology products, especially as they introduce new devices and services.
Economic Factors: Economic factors, including inflation and changes in consumer spending, could affect LogicMark's sales, particularly in the direct-to-consumer segment, which constitutes a significant portion of their customer base.
Technological Risks: As LogicMark invests in advanced technologies such as AI and IoT, there are inherent risks associated with technology adoption, integration, and potential cybersecurity threats that could impact their operations and customer trust.
Market Demand: The company must continuously assess market demand for their products and services, particularly in the context of changing consumer preferences and the growing need for personal safety solutions.
Revenue Growth: Achieved revenue growth of 13% in Q4 2023 compared to the same period last year.
Gross Profit Increase: 21% increase in gross profit in Q4 2023 compared to the same period last year.
Gross Margin Improvement: Annual gross margin for 2023 was the highest compared to the previous two years, with Q4 gross margin at 66%.
Product Launches: Introduced new products including Freedom Alert Plus and Freedom Alert Mini, enhancing the product line.
Patent Filings: Filed 12 patents since mid-2021, with 7 moved to final patent status.
Expansion of Distribution Channels: Focused on expanding distribution channels, including direct-to-consumer and health B2B opportunities.
New Software Application Launch: Launched Aster, a subscription-based software application for personal safety.
Government Contracts: Continued relationship with the Veterans Administration and contract with the U.S. General Services Administration.
2024 Focus: Continued focus on growing the health channel and expanding recurring revenue models.
Market Share Expansion: Plans to increase market share based on Care Economy Trends.
Financial Projections: Expect to boost sales and reduce customer acquisition costs through e-commerce channels.
Recurring Revenue Model: Intend to expand product line of cell-based safety solutions and integrate with third-party devices.
Net Loss Projections: Net loss for 2023 was $4.03 per share, with expectations for improved financial performance moving forward.
Deemed Dividend: A non-cash deemed dividend of $900,000 was recorded due to the warrant inducement transaction completed in November of 2023.
Share Repurchase Program: None
The earnings call presents a mixed picture: strong revenue growth and gross profit improvements are offset by rising operating expenses and unchanged net losses. The company's strategic initiatives in B2B expansion and recurring revenue are positive, but potential regulatory hurdles and economic uncertainties pose risks. The Q&A section reveals cautious management regarding VA funding, which adds uncertainty. Overall, while there are positive elements, the risks and unchanged net losses balance out, leading to a neutral prediction for stock price movement over the next two weeks.
The earnings call reveals stable financials with a 14% revenue increase and consistent gross margins, but ongoing net losses and competitive pressures. The Q&A indicates some uncertainty, especially around new product traction and vague management responses. The secondary offering and lack of a share repurchase program are negative factors. Overall, the sentiment is neutral due to balanced positive and negative aspects, and lack of market cap data limits prediction precision.
The earnings call summary indicates a mixed outlook. Positive aspects include revenue growth, gross margin improvement, and new product launches. However, financial challenges are evident with ongoing net losses and a secondary offering, which typically signals financial distress. The Q&A section reveals vague management responses, adding uncertainty. The reverse stock split and regulatory issues further complicate the outlook. Overall, the sentiment is balanced by positive product developments and market expansion against financial and regulatory concerns, resulting in a neutral stock price prediction.
The earnings call presents mixed signals: While revenue and gross profit increased, the net loss remains significant, and there's a notable goodwill impairment. The Q&A highlights potential product expansions and partnerships, but lacks concrete timelines or details. The company's cautious communication suggests uncertainty. Market reaction is likely neutral, as positive developments are offset by financial challenges and vague strategic plans.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.